Sharing knowledge through collaboration is at the heart of all we do.
Everything we do at DCRI is based on collaboration. Our researchers and operational teams work closely with each other, with our colleagues from the wider world of Duke University and Duke Health, and with our peers and partners around the world. As an independent academic research organization, we are able to challenge conventional approaches and explore innovative ways to accelerate the translation of scientific discovery into better care for patients everywhere.
What we offer:
- Full integration and close collaborations among faculty and operational leaders
- Fit-for-purpose trial design and operations
- Collaborative approach to academic leadership
- Mature North American site investigator networks that can be leveraged for for high-quality enrollment
- Streamlined data collection and adverse event reporting
- Focused, risk-based monitoring and predictive modeling
- Emphasis on study drug compliance and complete follow-up
- Shared endpoint adjudication activities
Collaborative Teams at Work
Analytics and Data Science at the DCRI
The biostatisticians in the DCRI Center for Predictive Medicine believe the answer to what’s next starts with asking the right question—early and often. At the DCRI, you benefit from the experience of Duke faculty statisticians and the real-world knowledge of practicing physicians helping to put your research on the right path from day one. By applying rigorous, best-in-class tools and algorithms, our biostatisticians and programmers craft research designs that help you to ask better questions and find the patterns within data that lead to stronger and more actionable insights. And we’re experts at linking data from diverse sources, including patient-generated data, electronic health records, clinical trials, insurance claims, and more to accelerate clinical, outcomes, and public-health research.
Collaborating to Improve Care
The DCRI pursues a collaborative approach with fellow academic institutions, patient advocacy groups, and public and private organizations throughout the world.
We are constantly exploring ways to actively engage with and empower patients as full partners in research. The DCRI works closely with patient advocacy groups across a wide variety of therapeutic areas to ensure that patient voices are heard at all stages of the research process.
Together with our extensive networks of site community partners, we’re addressing research challenges that will shape the future of medical care throughout the world. The DCRI's regional, national, and global collaborations make possible immediate access to physicians, nurses, and other healthcare personnel working at investigational sites around the world. Learn more by visiting our Site Community website.
Our close engagement with professional societies allows us to make meaningful contributions to developing and promoting new and updated clinical practice guidelines—an essential part of ensuring high-quality, evidence-based care. One recent example includes a joint initiative of the American Heart Association and the American Stroke Association called “Get With The Guidelines” (GWTG). This a hospital-based quality-improvement program is designed to improve the care and outcomes of patients with heart disease or stroke.
From its beginning, the DCRI has enjoyed close engagement with governmental entities, including the NIH and FDA. These partnerships have led to innovations in research design and conduct with significant impacts on patient care and public health. The DCRI currently serves as a coordinating center for projects including the NIH Health Care Systems Research Collaboratory and the Pediatric Trials Network, sponsored by the Eunice Kennedy Shriver National Institute of Child Health and Human Development.
We understand the vital role the medical products industry plays at multiple points along the spectrum of therapeutic development and evaluation. We are partnering with industry experts to achieve new insights into how patients use healthcare resources to manage their conditions, how to monitor the safety of therapies once they reach the market, and how to assess the effectiveness of clinical practice guidelines in improving care and outcomes. Ongoing initiatives such as the Affordability and Real-World Antiplatelet Treatment Effectiveness After Myocardial Infarction Study (ARTEMIS) and Patient and Provider Assessment of Lipid Management (PALM) study provide just two examples of the many innovative collaborations underway at the DCRI.
As part of Duke University, working collaboratively with other great institutions of learning around the world comes naturally to us. We are constantly seeking out these partnerships because we know that bringing fresh perspectives and different ways of thinking to any research challenge leads to better and more innovative solutions.